Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP238816.RATQm-AG4nmJvreCkecoxsWdI9qR_Ta4uCGC_wHt-2Zlg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP238816.RATQm-AG4nmJvreCkecoxsWdI9qR_Ta4uCGC_wHt-2Zlg130_assertion type Assertion NP238816.RATQm-AG4nmJvreCkecoxsWdI9qR_Ta4uCGC_wHt-2Zlg130_head.
- NP238816.RATQm-AG4nmJvreCkecoxsWdI9qR_Ta4uCGC_wHt-2Zlg130_assertion description "[Variations in solute carrier family 6A, member 3 (SLC6A3/DAT1), the human gene encoding DAT, have been implicated in attention deficit hyperactivity and bipolar disorders, and DAT is a prominent site of action for drugs such as amphetamines and cocaine.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP238816.RATQm-AG4nmJvreCkecoxsWdI9qR_Ta4uCGC_wHt-2Zlg130_provenance.
- NP238816.RATQm-AG4nmJvreCkecoxsWdI9qR_Ta4uCGC_wHt-2Zlg130_assertion evidence source_evidence_literature NP238816.RATQm-AG4nmJvreCkecoxsWdI9qR_Ta4uCGC_wHt-2Zlg130_provenance.
- NP238816.RATQm-AG4nmJvreCkecoxsWdI9qR_Ta4uCGC_wHt-2Zlg130_assertion SIO_000772 19504720 NP238816.RATQm-AG4nmJvreCkecoxsWdI9qR_Ta4uCGC_wHt-2Zlg130_provenance.
- NP238816.RATQm-AG4nmJvreCkecoxsWdI9qR_Ta4uCGC_wHt-2Zlg130_assertion wasDerivedFrom befree-20140225 NP238816.RATQm-AG4nmJvreCkecoxsWdI9qR_Ta4uCGC_wHt-2Zlg130_provenance.
- NP238816.RATQm-AG4nmJvreCkecoxsWdI9qR_Ta4uCGC_wHt-2Zlg130_assertion wasGeneratedBy ECO_0000203 NP238816.RATQm-AG4nmJvreCkecoxsWdI9qR_Ta4uCGC_wHt-2Zlg130_provenance.